Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N02CC01	IMIGRAN	B	Sumatriptan (succinate) - 50mg	50mg	Tablet, film coated	378,964 L.L
N01AB06	ISOFLURANE HIKMA	G	Isoflurane -		Volatil liquid	1,583,046 L.L
M02AA13	IBUSTICK	G	Ibuprofen - 50mg/g	50mg/g	Gel, roll on	857,372 L.L
M01AE51	IBUGESIC COLD AND SINUS	G	Ibuprofen - 200mg, Pseudoephedrine HCl - 30mg		Tablet, film coated	154,542 L.L
M01AE01	IBUSOL	G	Ibuprofen - 100mg/5ml	100mg/5ml	Suspension	309,724 L.L
M01AE01	IBUPROFEN B. BRAUN	G	Ibuprofen - 400mg/100ml	400mg/100ml	Injectable solution	231,141 L.L
M01AE01	IBUPROFEN B. BRAUN	G	Ibuprofen - 200mg/50ml	200mg/50ml	Injectable solution	161,261 L.L
M01AE01	IBUPROFEN B. BRAUN	G	Ibuprofen - 600mg/100ml	600mg/100ml	Injectable solution	550,975 L.L
M01AC01	INFLACAM	G	Piroxicam - 20mg/ml	20mg/ml	Injectable solution	193,513 L.L
M01AC01	INFLACAM	G	Piroxicam - 20mg/ml	20mg/ml	Injectable solution	190,826 L.L
M01AB01	INDOMEL	G	Indometacin - 25mg	25mg	Capsule	170,220 L.L
M01AB01	INDOCID	B	Indometacin - 100mg	100mg	Suppository	424,910 L.L
M01AB01	INDOMEL	G	Indometacin - 100mg	100mg	Suppository	222,694 L.L
L04AX06	IMNOVID	B	Pomalidomide - 4mg	4mg	Capsule, hard	L.L
L04AX06	IMNOVID	B	Pomalidomide - 2mg	2mg	Capsule, hard	407,188,707 L.L
L04AX06	IMNOVID	B	Pomalidomide - 4mg	4mg	Capsule, hard	417,741,356 L.L
L04AX01	IMURAN	B	Azathioprine - 50mg	50mg	Tablet	2,030,546 L.L
L04AB02	IXIFI	BioTech	Infliximab - 100mg	100mg	Injectable powder for concentrate for solution	L.L
L04AB02	INFLIXIREL	BioTech	Infliximab - 100mg	100mg	Injectable concentrate for solution	18,065,957 L.L
L04AB02	IXIFI	BioTech	Infliximab - 100mg	100mg	Injectable powder for concentrate for solution	23,911,751 L.L
L04AA06	IMUNOCELL	G	Mycophenolate mofetil - 500mg	500mg	Tablet, film coated	3,791,428 L.L
L03AB03	IMUKIN	BioTech	Interferon gamma - 100mcg/0.5ml	100mcg/0.5ml	Injectable suspension	6,348,312 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 500mg/10ml	500mg/10ml	Injectable solution	L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 500mg/10ml	500mg/10ml	Injectable solution	L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 500mg/10ml	500mg/10ml	Injectable solution	227,939,689 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 500mg/10ml	500mg/10ml	Injectable solution	227,939,689 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 120mg/2.4ml	120mg/2.4ml	Injectable solution	59,776,110 L.L
L01FF03	IMFINZI	BioTech	Durvalumab - 120mg/2.4ml	120mg/2.4ml	Injectable solution	59,776,110 L.L
L01EL01	IMBRUVICA	B	Ibrutinib - 420mg	420mg	Tablet, film coated	L.L
L01EL01	IMBRUVICA	B	Ibrutinib - 140mg	140mg	Tablet, film coated	194,761,420 L.L